Minskintercaps is a leader in the national pharmaceutical industry in the production of prescription and over-the-counter medications and biologically active food additives in the form of soft and hard gelatin capsules, incl. for oral, vaginal and rectal use. For 35 years, the company has been providing consumers with effective, high-quality and safe drugs that are available to all segments of the population. The company's product portfolio contains about 100 items (including forms and dosages). These are drugs used to treat the cardiovascular system, gastrointestinal tract, nervous system, liver diseases, colds and flu, diseases of the joints and spine, diabetes, allergies, hemorrhoids and varicose veins, NSAIDs, for women's and men's health, as well as vitamins and vitamin-mineral complexes. Minskintercaps is the first manufacturer in the CIS countries to master the production of medications in the form of vaginal (2008) and rectal capsules (2018). In 2020, the company introduced an innovative dosage form – chewable capsules – to the Belarusian pharmaceutical market for the first time. In 2024, the Minskintercaps Unitary Enterprise mastered the production of products in the form of chewable lozenges and tablets. Minskintercaps carries out the production of the full technological cycle: from control of incoming raw materials and materials to the final product in consumer packaging. The chemical and microbiological laboratory of the enterprise is accredited for technical competence in accordance with the requirements of STB ISO/IEC 17025. The production is equipped with technological equipment from the world's leading companies TECHNOPHAR (Canada), GIC (USA), IMA (Italy), BOSCH (Germany). Minskintercaps is a leader in the national pharmaceutical industry, producing prescription and over-the-counter medications and dietary supplements in soft and hard gelatin capsules, including oral, vaginal, and rectal capsules. For 35 years, the company has provided consumers with effective, high-quality, and safe medications that are accessible to all segments of the population. The company's product portfolio contains approximately 100 products (including forms and dosages). These include medications used to treat the cardiovascular system, gastrointestinal tract, nervous system, liver disease, colds and flu, joint and spine conditions, diabetes, allergies, hemorrhoids and varicose veins, NSAIDs, women's and men's health, vitamins and vitamin-mineral complexes. Minskintercaps was the first manufacturer in the CIS to launch the production of medicinal products in the form of vaginal (2008) and rectal (2018) capsules. In 2020, the company introduced an innovative dosage form – chewable capsules – to the Belarusian pharmaceutical market. In 2024, Minskintercaps UP launched the production of chewable lozenges and tablets. Minskintercaps carries out the full production cycle, from the inspection of incoming raw materials and supplies to the final product in consumer packaging. The company's chemical and microbiological laboratory is accredited for technical competence in accordance with the requirements of STB ISO/IEC 17025. The production facility is equipped with technological equipment from leading global companies such as TECHNOPHAR (Canada), GIC (USA), IMA (Italy), and BOSCH (Germany).